Furthermore, research by another team has demonstrated that T cell-mediated tumor reactivity manifests in brain metastases, characterized by the enrichment of CD39+ T cells expressing CXCL13, which are potential tumor-reactive T cells (pTRT) [35]. Here, ENTPD1 is linked to neoplasm.